Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
Ito K, Kuno A, Ikehara Y, Sugiyama M, Saito H, Aoki Y, Matsui T, Imamura M, Korenaga M, Murata K, Masaki N, Tanaka Y, Hige S, Izumi N, Kurosaki M, Nishiguchi S, Sakamoto M, Kage M, Narimatsu H, Mizokami M. Ito K, et al. Among authors: matsui t. Hepatology. 2012 Oct;56(4):1448-56. doi: 10.1002/hep.25815. Hepatology. 2012. PMID: 22535703
Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients.
Saito H, Ito K, Sugiyama M, Matsui T, Aoki Y, Imamura M, Murata K, Masaki N, Nomura H, Adachi H, Hige S, Enomoto N, Sakamoto N, Kurosaki M, Mizokami M, Watanabe S. Saito H, et al. Among authors: matsui t. Hepatol Res. 2012 Oct;42(10):958-65. doi: 10.1111/j.1872-034X.2012.01013.x. Epub 2012 Apr 26. Hepatol Res. 2012. PMID: 22536875
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.
Murata K, Sugiyama M, Kimura T, Yoshio S, Kanto T, Kirikae I, Saito H, Aoki Y, Hiramine S, Matsui T, Ito K, Korenaga M, Imamura M, Masaki N, Mizokami M. Murata K, et al. Among authors: matsui t. J Gastroenterol. 2014 Jan;49(1):126-37. doi: 10.1007/s00535-013-0814-1. Epub 2013 Apr 17. J Gastroenterol. 2014. PMID: 23591768 Free PMC article.
[Primary adenosquamous carcinoma of the liver presenting with hematochezia due to tumor invasion of the colon].
Takeda T, Murata K, Ikeda M, Chatani N, Kobayashi M, Aoki Y, Matsui T, Korenaga M, Imamura M, Masaki N, Aoki Y, Ogami T, Yada T, Koizuka H, Aoyanagi N, Ishida T, Watanabe S, Uemura N, Mizokami M. Takeda T, et al. Among authors: matsui t. Nihon Shokakibyo Gakkai Zasshi. 2013 Nov;110(11):1959-67. Nihon Shokakibyo Gakkai Zasshi. 2013. PMID: 24189825 Japanese.
Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease.
Tezuka T, Ishiguro M, Taniguchi D, Osogaguchi E, Shiba-Fukushima K, Ogata J, Ishii R, Ikeda A, Li Y, Yoshino H, Matsui T, Kaida K, Funayama M, Nishioka K, Kumazawa F, Matsubara T, Tsuda H, Saito Y, Murayama S, Imai Y, Hattori N. Tezuka T, et al. Among authors: matsui t. Neurobiol Dis. 2024 Jun 18:106571. doi: 10.1016/j.nbd.2024.106571. Online ahead of print. Neurobiol Dis. 2024. PMID: 38901781
Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity.
Shoji K, Hikino K, Saito J, Matsui T, Utano T, Takebayashi A, Tomizawa D, Kato M, Matsumoto K, Ishikawa T, Kawai T, Nakamura H, Miyairi I, Terao C, Mushiroda T. Shoji K, et al. Among authors: matsui t. J Infect Chemother. 2024 Jun 17:S1341-321X(24)00164-8. doi: 10.1016/j.jiac.2024.06.009. Online ahead of print. J Infect Chemother. 2024. PMID: 38897411
DNA Aptamer Raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing Receptors for Advanced Glycation End Product-Induced Oxidative Stress and Inflammation in the Testes of Diabetic Mice.
Mori Y, Terasaki M, Osaka N, Fujikawa T, Yashima H, Saito T, Kataoka Y, Ohara M, Higashimoto Y, Matsui T, Yamagishi SI. Mori Y, et al. Among authors: matsui t. Int J Mol Sci. 2024 May 29;25(11):5947. doi: 10.3390/ijms25115947. Int J Mol Sci. 2024. PMID: 38892134 Free PMC article.
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial.
Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Matsuura S, Nishimoto K, Matsui T, Asada K, Hashimoto D, Fujii M, Niwa M, Uehara M, Matsuda H, Koda K, Ikeda M, Inami N, Tamiya Y, Kato M, Nakano H, Mino Y, Enomoto N, Suda T. Inui N, et al. Among authors: matsui t. J Clin Oncol. 2024 Jun 4:JCO2400278. doi: 10.1200/JCO.24.00278. Online ahead of print. J Clin Oncol. 2024. PMID: 38833659
4,244 results